Last reviewed · How we verify
NCT05905588
Study of Hydrogen-rich Water Compared With Placebo in Type 2 Diabetes Patients
NA trial testing Hydrogen-rich water in Type 2 Diabetes in 96 participants. Status unknown.
31 August 2023
Quick facts
| Lead sponsor | Qingdao University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 96 |
| Start date | 1 March 2023 |
| Primary completion | 31 August 2023 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Hydrogen-rich water
- placebo
Conditions studied
- Type 2 Diabetes — all drugs for Type 2 Diabetes →
Sponsor
Qingdao University
Who can join
Adults 18 to 75, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the efficacy and safety of hydrogen-rich water in type 2 diabetes patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05905588
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hydrogen-rich water
Trials testing the same drug.
- NCT07410065 — Supersaturated Hydrogen-Rich Water for Outpatients With Persistent Excess Weight · NA · not yet recruiting
- NCT04430803 — Hydrogen-rich Water for Molecular and Phenotypic Biomarkers of Aging · NA · completed
- NCT04167202 — Hydrotherapy With Hydrogen-rich Water vs. RICE Protocol Following Acute Ankle Sprain · NA · completed
Other recruiting trials for Type 2 Diabetes
Currently open trials in the same condition.
- NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
- NCT07254689 — The Food for Health Study · NA · recruiting
- NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting
Other Qingdao University trials
Trials by the same sponsor.
- NCT06359977 — The Effect of Quantitative EEG Combined With Ultrasound and Sputum Volume on Predicting Weaning Failure · not yet recruiting
- NCT06083831 — The Effect of Sequential Feeding for Circadian Rhythm and Gut Flora Rhythm in Critically Ill Patients · unknown
- NCT05842993 — Study of Hydrogen Inhalation Compared With Placebo in Type 2 Diabetes Patients · NA · unknown
- NCT04443335 — Comparison of Continuous Feeding and Sequential Feeding on Gut Microbiota and Metabolomics in Critically Ill Patients · NA · completed
- NCT03552601 — The Effect of Negatively Fluid Balancing Speed for ICU Patients With Acute Respiratory Distress Syndrome · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05905588 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qingdao University
- Last refreshed: 15 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05905588.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing